Lori Clapper

India’s government is offering significant cash rewards to whistleblowers, in hopes of pulling the plug on counterfeit pharmaceutical operations. The country's Central Drugs Standards Control Organization (CDSCO) says informants who turn in criminals who market fake drugs, devices, and cosmetics, can get paid up to 20 percent of the total value of the intercepted shipments that are "spurious, adulterated and/or...  Continue Reading..

In an effort to encourage the distribution of generic medicines to the poor population in India, the U.S. Food and Drug Administration (FDA) is issuing prescription guidelines to pharmacists, so they can relay the new rules to doctors.  Continue Reading..

India’s government has just thrown domestic drug makers a curve ball, announcing changed pharmaceutical serialization requirements for all drug exports. The country now considers mono cartons as secondary level rather than primary packaging, contradicting its announcement to the industry in October 2013, which indicated that these package types should be considered primary.  Continue Reading..

West Pharmaceuticals Services (WPS), a producer and packager of delivery systems for sterile drug manufacturing, has launched a new $15 million Indian facility in Sri City, near Chennai. The plant will be used to produce seals in primary packaging of injectable medicines. It will also be fully oriented around exports and will aim to service pharma and biopharma customers in India and the wider Asia Pacific region (APAC), The Hindu reports.  Continue Reading..

The National Institute for Health and Care Excellence (NICE) has fallen under intense scrutiny, after new research found that it has denied most potential new cancer medicines or has imposed strict restrictions on them, limiting access to patients who need them.  Continue Reading..

Sun Pharma announced Wednesday that it has acquired Pharmalucence, a company best known for manufacturing radiopharmaceuticals. The company was purchased by one of Sun Pharma’s U.S.-based subsidiaries, which is hoping to complete the transaction by the end of 2014. Financial details of the deal have not been disclosed.  Continue Reading..

Despite the enactment of the Generating Antibiotic Incentives Now (GAIN) Act of 2012, the U.S. Food and Drug Administration (FDA) is still lagging behind the European Medicines Agency (EMA) in antibiotic research and development, according to research and consulting firm GlobalData.  Continue Reading..

India-based Glenmark Pharmaceuticals, one of the leading global pharmaceutical manufacturers, is planning to build a $100 million state-of-the-art manufacturing facility to serve the U.S. market. The company hopes this move will shed some of the negative publicity Indian pharma companies have received in the past year due to quality issues, as well as de-risk its future growth strategy, the Times of India reported.  Continue Reading..

Abbott Laboratories says it will sell its developed markets branded generics pharmaceuticals business to Mylan. The exchange will combine Mylan's existing business and Abbott's developed markets pharmaceuticals business into an estimated $5.3 billion company.  Continue Reading..

The Centre for Process Innovation (CPI) announced on Thursday it will invest £20m to build what it calls a “Biologics Factory of the Future.” Tees Valley Unlimited Enterprise Partnership awarded half of the funding— £10m—for the project, which is expected to open in 2017.  Continue Reading..